Form 8-K - Current report:
SEC Accession No. 0001829126-25-002326
Filing Date
2025-04-02
Accepted
2025-04-02 16:05:16
Documents
14
Period of Report
2025-04-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zeoscientifix_8k.htm   iXBRL 8-K 35288
2 EXHIBIT 10.1 zeoscientifix_ex10-1.htm EX-10.1 71150
  Complete submission text file 0001829126-25-002326.txt   292408

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ocel-20250401.xsd EX-101.SCH 2990
4 XBRL LABEL FILE ocel-20250401_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE ocel-20250401_pre.xml EX-101.PRE 22342
16 EXTRACTED XBRL INSTANCE DOCUMENT zeoscientifix_8k_htm.xml XML 3346
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Zeo ScientifiX, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 25804312
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)